In the realm of joint health supplements, consumers have long been accustomed to powders and capsules as their primary choices. These formats have served their purpose well, but they often come with certain challenges.
Sirio Europe (SIRIO) – the leading global nutraceuticals contract development and manufacturing organization (CDMO) – will launch two new softgels targeted at customers who look to innovate in the consumer health space at CPHI Barcelona. The new formulations are designed to meet the rising demand of consumers for products with more natural actives for both menopause and improved eye health.
